IP Verse

Adam6 Mice - EP2578688

The patent EP2578688 was granted to Regeneron Pharmaceuticals on Feb 8, 2023. The application was originally filed on Feb 24, 2012 under application number EP12192727A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2578688

REGENERON PHARMACEUTICALS
Application Number
EP12192727A
Filing Date
Feb 24, 2012
Status
Patent Maintained As Amended
Jan 6, 2023
Grant Date
Feb 8, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

KYMABMay 4, 2020CMS CAMERON MCKENNA NABARRO OLSWANGADMISSIBLE

Patent Citations (20) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2007280945
DESCRIPTIONUS6586251
DESCRIPTIONUS6596541
DESCRIPTIONUS7105348
DESCRIPTIONUS7294754
DESCRIPTIONUS7473557
DESCRIPTIONUS7576259
DESCRIPTIONUS7659442
EXAMINATIONWO2011004192
EXAMINATIONWO2011158009
EXAMINATIONWO2013061098
EXAMINATIONWO2013079953
OPPOSITIONEP2550363
OPPOSITIONWO02066630
OPPOSITIONWO2011004192
OPPOSITIONWO2011158009
OPPOSITIONWO2013079953
OTHEREP2793567
OTHERWO02066630
SEARCHUS2004018626

Non-Patent Literature (NPL) Citations (75) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ALT ET AL., "Immunoglobulin genes in transgenic mice", TRENDS GENET, (1985), vol. 1, pages 231 - 236-
DESCRIPTION- BRAMBELL, "A Theoretical Model of Gamma-Globulin Catabolism", NATURE, (1964), vol. 203, pages 1352 - 1354-
DESCRIPTION- BRIL ET AL., "Tolerance to factor Vlll in a transgenic mouse expressing human factor VIII cDNA carrying an Arg(593) to Cys substitution", THROMB HAEMOST, (2006), vol. 95, pages 341 - 347-
DESCRIPTION- BRUGGEMANN ET AL., "A repertoire of monoclonal antibodies with human heavy chains from transgenic mice", PNAS, (1989), vol. 86, pages 6709 - 6713-
DESCRIPTION- BUCHHOLZ ET AL., "Improved properties of FLP recombinase evolved by cycling mutagenesis", NAT BIOTECHNOL, (1998), vol. 16, pages 657 - 662-
DESCRIPTION- FEENEY, "Factors that influence formation of B cell repertoire", LMMUNOL RES, (2000), vol. 21, pages 195 - 202-
DESCRIPTION- GARRETT ET AL., "Chromatin architecture near a potential 3' end of the IgH locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites", MOL CELL BIOL, (2005), vol. 25, pages 1511 - 1525-
DESCRIPTION- GIBSON ET AL., "Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer", CLIN COLORECTAL CANCER, (2006), vol. 6, pages 29 - 31-
DESCRIPTION- GREEN ET AL., "Antigen-specific human monoclonal antibodies from mice engineered with human lg heavy and light chain YACs", NAT GENET, (1994), vol. 7, pages 13 - 21-
DESCRIPTION- GREEN; JAKOBOVITS, "Regulation of B cell development by variable gene complexity in mice reconstituted with human immunoglobulin yeast artificial chromosomes", J EXP MED, (1998), vol. 188, pages 483 - 495-
DESCRIPTION- HJELM ET AL., "Antibody-mediated regulation of the immune response", SCAND J LMMUNOL, (2006), vol. 64, pages 177 - 184-
DESCRIPTION- HOMANICS ET AL., "Production and characterization of murine models of classic and intermediate maple syrup urine disease", BMC MED GENET, (2006), vol. 7, page 33-
DESCRIPTION- HOMBACH ET AL., "Molecular components of the B-cell antigen receptor complex of the IgM class", NATURE, (1990), vol. 343, pages 760 - 762-
DESCRIPTION- JAKOBOVITS ET AL., "From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice", NAT BIOTECHNOL, (2007), vol. 25, pages 1134 - 1143-
DESCRIPTION- JAMSAI, "A humanized BAC transgenic/knockout mouse model for HbE/beta-thalassemia", GENOMICS, (2006), vol. 88, no. 3, pages 309 - 15-
DESCRIPTION- JUNGHANS; ANDERSON, "The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor", PNAS USA, (1996), vol. 93, pages 5512 - 5516-
DESCRIPTION- KATAOKA ET AL., "Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch", PNAS USA, (1980), vol. 77, pages 919 - 923-
DESCRIPTION- KIM ET AL., "Clinical efficacy of zanolimumab (HuMax-CD4): two Phase II studies in refractory cutaneous T-cell lymphoma", BLOOD, (2007), vol. 109, no. 11, pages 4655 - 62-
DESCRIPTION- LONBERG ET AL., "Antigen-specific human antibodies from mice comprising four distinct genetic modifications", NATURE, (1994), vol. 368, pages 856 - 859-
DESCRIPTION- LONBERG, "Human antibodies from transgenic animals", NAT BIOTECHNOL, (2005), vol. 23, pages 1117 - 1125-
DESCRIPTION- MAKER ET AL., "Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte- associated antigen 4 blockade and interleukin 2: a phase I/II study", ANN SURG ONCOL, (2005), vol. 12, pages 1005 - 1016-
DESCRIPTION- MANIS ET AL., "Elucidation of a downstream boundary of the 3' IgH regulatory region", MOL LMMUNOL, (2003), vol. 39, pages 753 - 760-
DESCRIPTION- MATSUDA ET AL., "The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus", J EXP MED, (1998), vol. 188, pages 2151 - 2162-
DESCRIPTION- MCCLUNG ET AL., "Denosumab in postmenopausal women with low bone mineral density", NEW ENGL J MED, (2006), vol. 354, pages 821 - 831-
DESCRIPTION- MCLEOD, "Identification of the crossover site during FLP-mediated recombination in the Saccharomyces cerevisiae plasmid 2 microns circle", MO! CELL BIOL, (1986), vol. 6, pages 3357 - 3367-
DESCRIPTION- MICHAEL, MECH. DEV., (1999), vol. 85, pages 35 - 47-
DESCRIPTION- MORTENSEN ET AL., "Production of homozygous mutant ES cells with a single targeting construct", MOL CELL BIOL, (1992), vol. 12, pages 2391 - 2395-
DESCRIPTION- NEUBERGER, "Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells", EMBO J, (1983), vol. 2, pages 1373 - 1378-
DESCRIPTION- NIMMERJAHN; RAVETCH, "Fc-receptors as regulators of immunity", ADV LMMUNOL, (2007), vol. 96, pages 179 - 204-
DESCRIPTION- PAN ET AL., "Different role for mouse and human CD3delta/epsilon heterodimer in preT cell receptor (preTCR) function:human CD3deltalepsilon heterodimer restores the defective preTCR function in CD3gamma- and CD3gammadelta-deficient mice", MOL LMMUNOL, (2006), vol. 43, pages 1741 - 1750-
DESCRIPTION- PAWLITZKY ET AL., "Identification of a candidate regulatory element within the 5' flanking region of the mouse IgH locus defined by pro-B cell-specific hypersensitivity associated with binding of PU.1, Pax5, and E2A", J IMMUNOL, (2006), vol. 176, pages 6839 - 6851-
DESCRIPTION- POUEYMIROU ET AL., "FO generation mice fully derived from gene-targeted embryonic stem cells allowing immediate phenotypic analyses", NAT BIOTECHNOL, (2007), vol. 25, pages 91 - 99-
DESCRIPTION- RAO ET AL., "Differential expression of the inhibitory IgG Fc receptor FcgammaRIIB on germinal center cells: implications for selection of high-affinity B cells", J LMMUNOL, (2002), vol. 169, pages 1859 - 1868-
DESCRIPTION- RODRIGUEZ ET AL., "High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP", NATURE GENETICS, (2000), vol. 25, pages 139 - 140-
DESCRIPTION- SCHAIBLE ET AL., "The immunoglobulin kappa locus; polymorphism and haplotypes of Caucasoid and non-Caucasoid individuals", HUM GENET, (1993), vol. 91, pages 261 - 267-
DESCRIPTION- SCHWARTZ; CANTOR, "Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis", CELL, (1984), vol. 37, pages 67 - 75-
DESCRIPTION- TOMIZUKA ET AL., "Double trans-chromosomic mice: maintenance of two individual human chromosome fragments containing Ig heavy and kappa loci and expression of fully human antibodies", PNAS USA, (2000), vol. 97, pages 722 - 727-
DESCRIPTION- TUAILLON ET AL., "Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene- segment use in mu and gamma transcripts", PNAS USA, (1993), vol. 90, pages 3720 - 3724-
DESCRIPTION- VALENZUELA ET AL., "High-throughput engineering of the mouse genome coupled with high-resolution expression analysis", NAT BIOTECHNOL, (2003), vol. 21, pages 652 - 659-
DESCRIPTION- WALLACE ET AL., NUCLEIC ACIDS RES., (2000), vol. 28, pages 1455 - 1464-
DESCRIPTION- WANG; STOLLAR, "Human immunoglobulin variable region gene analysis by single cell RT-PCR", J IMMUNOL METHODS, (2000), vol. 244, pages 217 - 225-
DESCRIPTION- WATERSTON ET AL., "Initial sequencing and comparative analysis of the mouse genome", NATURE, (2002), vol. 420, pages 520 - 562-
DESCRIPTION- WEICHHOLD ET AL., "The human immunoglobulin kappa locus consists of two copies that are organized in opposite polarity", GENOMICS, (1993), vol. 16, pages 503 - 511-
DESCRIPTION- ZAMBROWICZ ET AL., PNAS USA, (1997), vol. 94, pages 3789 - 3794-
DESCRIPTION- ZHANG, "A new logic for DNA engineering using recombination in Escherichia coli", NAT GENET, (1998), vol. 20, pages 123 - 128-
DESCRIPTION- ZHENG ET AL., "Engineering mouse chromosomes with Cre-oxP: range, efficiency, and somatic applications", MOL CELL BIOL, (2000), vol. 20, pages 648 - 655-
EXAMINATION- E-CHIANG LEE ET AL, "Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery", NATURE BIOTECHNOLOGY, (20140316), vol. 32, no. 4, doi:10.1038/nbt.2825, ISSN 1087-0156, pages 356 - 363, XP055131583
OPPOSITION- AUSTIN et al., "The Knockout Mouse Project", NATURE GENETICS, (20040901), vol. 36, no. 9, pages 921 - 924-
OPPOSITION- "Chapter 10 Knockin Approaches", ROEBROEK et al., Methods in Molecular Biology. Transgenic mouse methods and protocols, Humana Press, (20030000), vol. 209, pages 187 - 200-
OPPOSITION- "Chapter 10 Knockin Approaches", ROEBROEK et al., Methods in Molecular Biology. Transgenic mouse methods and protocols, Humana Press, (20030000), vol. 209, pages 187 - 200, XP055699110-
OPPOSITION- "Chapter 8 Gene -Targeting Strategies", MELTON et al, Methods in Molecular Biology, Transgenesis Techniques - Principles and Protocols, 2nd ed, Humana Press, (20020000), pages 151 - 173, ISBN 978-0-89603-696-0-
OPPOSITION- "Chapter 8 Gene -Targeting Strategies", MELTON et al, Methods in Molecular Biology, Transgenesis Techniques - Principles and Protocols, 2nd ed, Humana Press, (20020000), pages 151 - 173, ISBN 978-0-89603-696-0, XP055497679-
OPPOSITION- Drew Murphy, "BAC-based Modifications of the Mouse Genome: The Big and the Backward", Genetic Manipulation of ES Cells, (20091103), pages 1 - 58, XP002752689-
OPPOSITION- HIROHATA et al., "Chromosomal Assignment of Two ADAM Genes, TACE (ADAM17) and MLTNB (ADAM19), to Human Chromosomes 2 and 5, Respectively, and ofMltnbto Mouse Chromosome 11", GENOMICS, (19981115), vol. 54, no. 1, pages 178 - 179-
OPPOSITION- HOIRUCHI et al, "Chapter 2 STUDIES FROM ADAM KNOCKOUT MICE", HOIRUCHI et al, HOIRUCHI K. et al, The ADAM Family or Protease, Springer, (20050000), pages 29 - 64-
OPPOSITION- "Targeted Modification of Mammalian Genomes", SORRELL et al., Focus on Genome Research, Nova Biomedical Books, (20040000), page 367-
OPPOSITION- "Targeted Modification of Mammalian Genomes", SORRELL et al., Focus on Genome Research, Nova Biomedical Books, (20040000), page 367, XP055699564-
OPPOSITION- "Veloclmmune: Immunoglobulin Variable Region Humanized Mice", MURPHY et al, Recombinant Antibodies for Immunotherapy, Cambridge University Press, (20090000), pages 100 - 107-
OPPOSITION- VORONINA et al., "Deletion of Adam6 in Mus musculus leads to male subfertility and deficits in sperm ascent into the oviduct", Biology of Reproduction, (20190228), vol. 100, no. 3, doi:10.1093/biolre/ioy210, pages 686 - 696-
OPPOSITION- HIROHATA et al., "Chromosomal Assignment of Two ADAM Genes, TACE (ADAM17) and MLTNB (ADAM19), to Human Chromosomes 2 and 5, Respectively, and ofMltnbto Mouse Chromosome 11", GENOMICS, (19981115), vol. 54, no. 1, pages 178 - 179, XP004448970
OPPOSITION- HOIRUCHI et al, "Chapter 2 STUDIES FROM ADAM KNOCKOUT MICE", HOIRUCHI et al, HOIRUCHI K. et al, The ADAM Family or Protease, Springer, (20050000), pages 29 - 64, XP055302416
OPPOSITION- EDWARDS D. R. et al., "The ADAM metalloproteinases", MOLECULAR ASPECTS OF MEDICINE, (20080815), vol. 29, no. 5, pages 258 - 289, XP025473840
OPPOSITION- CHOI et al., "Characterization and comparative genomic analysis of intronless Adams with testicular gene expression", GENOMICS, (20040401), vol. 83, no. 4, pages 636 - 646, XP004495995
OPPOSITION- "Veloclmmune: Immunoglobulin Variable Region Humanized Mice", MURPHY et al, Recombinant Antibodies for Immunotherapy, Cambridge University Press, (20090000), pages 100 - 107, XP055343725
OPPOSITION- LEE et al., "Complete humanization of the mouse immunoglobulin loci enables efficient therapeutic antibody discovery", Nature Biotechnology, (20140401), vol. 32, no. 4, pages 356 - 363, XP055131583
OPPOSITION- AUSTIN et al., "The Knockout Mouse Project", NATURE GENETICS, (20040901), vol. 36, no. 9, pages 921 - 924, XP002451005
OPPOSITION- FEATHERSTONE et al., "The Mouse Immunoglobulin Heavy Chain V-D Intergenic Sequence Contains Insulators That May Regulate Ordered V(D)J Recombination", (20100125), vol. 285, no. 13, pages 9327 - 9338, XP002677428
OPPOSITION- VORONINA et al., "Deletion of Adam6 in Mus musculus leads to male subfertility and deficits in sperm ascent into the oviduct", Biology of Reproduction, (20190228), vol. 100, no. 3, doi:10.1093/biolre/ioy210, pages 686 - 696, XP009517388
OPPOSITION- HAN et al., "Comprehensive analysis of reproductive ADAMs: relationship of ADAM4 and ADAM6 with an ADAM complex required for fertilization in mice", Biology of Reproduction, (20090107), vol. 80, no. 5, pages 1001 - 1008, XP002677427
OTHER- Drew Murphy, "SAC-based Modifications of the Mouse Genome:The Big and the Backward", Wellcome Trust Advanced Course: Genetic Manioulation of ES Cells, (20091103), pages 1 - 58, XP002752689-
SEARCH- EDWARDS D R ET AL, "The ADAM metalloproteinases", MOLECULAR ASPECTS OF MEDICINE, PERGAMON PRESS, OXFORD, GB, vol. 29, no. 5, doi:10.1016/J.MAM.2008.08.001, ISSN 0098-2997, (20091001), pages 258 - 289, (20080815), XP025473840 [A] 1-15 * the whole document *
SEARCH- CHOI I ET AL, "Characterization and comparative genomic analysis of intronless Adams with testicular gene expression", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, (20040401), vol. 83, no. 4, doi:10.1016/J.YGENO.2003.10.001, ISSN 0888-7543, pages 636 - 646, XP004495995 [A] 1-15 * the whole document *
SEARCH- LONBERG NILS, "Human antibodies from transgenic animals", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, (20050901), vol. 23, no. 9, doi:10.1038/NBT1135, ISSN 1087-0156, pages 1117 - 1125, XP002442149 [AD] 1-15 * figure 3 * * page 1119 - page 1120 *
SEARCH- FEATHERSTONE KAREN ET AL, "The Mouse Immunoglobulin Heavy Chain V-D Intergenic Sequence Contains Insulators That May Regulate Ordered V(D)J Recombination", JOURNAL OF BIOLOGICAL CHEMISTRY, (201003), vol. 285, no. 13, ISSN 0021-9258, pages 9327 - 9338, XP002677428 [A] 1-15 * page 9331 * * page 9332 * * page 9336 *
SEARCH- HAN CECIL ET AL, "Comprehensive analysis of reproductive ADAMs: relationship of ADAM4 and ADAM6 with an ADAM complex required for fertilization in mice.", BIOLOGY OF REPRODUCTION MAY 2009 LNKD- PUBMED:19129510, (200905), vol. 80, no. 5, ISSN 0006-3363, pages 1001 - 1008, XP002677427 [A] 1-15 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents